Wall Street analysts predict that Cross Country Healthcare, Inc. (NASDAQ:CCRN) will post $226.29 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Cross Country Healthcare’s earnings, with estimates ranging from $226.02 million to $226.56 million. Cross Country Healthcare posted sales of $222.52 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 1.7%. The business is scheduled to issue its next quarterly earnings results on Wednesday, March 7th.

On average, analysts expect that Cross Country Healthcare will report full-year sales of $226.29 million for the current year, with estimates ranging from $871.39 million to $871.94 million. For the next fiscal year, analysts expect that the business will report sales of $940.37 million per share, with estimates ranging from $940.11 million to $940.64 million. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that cover Cross Country Healthcare.

Cross Country Healthcare (NASDAQ:CCRN) last issued its earnings results on Wednesday, November 1st. The business services provider reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.05. The business had revenue of $228.50 million during the quarter, compared to analysts’ expectations of $228.97 million. Cross Country Healthcare had a net margin of 0.19% and a return on equity of 11.69%. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.24 earnings per share.

Several research analysts have issued reports on CCRN shares. TheStreet raised shares of Cross Country Healthcare from a “c+” rating to a “b” rating in a report on Wednesday, September 27th. Zacks Investment Research cut shares of Cross Country Healthcare from a “hold” rating to a “sell” rating in a report on Tuesday, October 3rd. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $18.00 target price on shares of Cross Country Healthcare in a report on Wednesday, November 1st. BMO Capital Markets decreased their target price on shares of Cross Country Healthcare from $15.00 to $14.00 and set an “outperform” rating for the company in a report on Monday, November 6th. Finally, Credit Suisse Group started coverage on shares of Cross Country Healthcare in a report on Tuesday, November 7th. They issued a “neutral” rating and a $13.00 target price for the company. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Cross Country Healthcare presently has a consensus rating of “Buy” and an average target price of $15.31.

Shares of Cross Country Healthcare (NASDAQ CCRN) traded down $0.13 during trading on Wednesday, reaching $12.60. 202,489 shares of the company’s stock traded hands, compared to its average volume of 237,757. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.14 and a quick ratio of 2.14. The stock has a market capitalization of $459.83, a PE ratio of 630.00, a PEG ratio of 1.63 and a beta of 0.75. Cross Country Healthcare has a twelve month low of $11.07 and a twelve month high of $16.38.

In other news, General Counsel Susan E. Ball sold 25,000 shares of Cross Country Healthcare stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $14.19, for a total value of $354,750.00. Following the completion of the sale, the general counsel now directly owns 126,921 shares in the company, valued at $1,801,008.99. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Thomas C. Dircks purchased 10,000 shares of Cross Country Healthcare stock in a transaction dated Monday, November 6th. The stock was bought at an average price of $11.77 per share, with a total value of $117,700.00. Following the completion of the purchase, the director now directly owns 104,571 shares of the company’s stock, valued at $1,230,800.67. The disclosure for this purchase can be found here. Insiders own 3.90% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. TIAA CREF Investment Management LLC grew its stake in shares of Cross Country Healthcare by 0.3% in the second quarter. TIAA CREF Investment Management LLC now owns 212,793 shares of the business services provider’s stock worth $2,747,000 after acquiring an additional 614 shares during the period. Voya Investment Management LLC grew its position in Cross Country Healthcare by 16.9% during the second quarter. Voya Investment Management LLC now owns 18,329 shares of the business services provider’s stock valued at $237,000 after buying an additional 2,646 shares during the period. Legal & General Group Plc grew its position in Cross Country Healthcare by 5.8% during the second quarter. Legal & General Group Plc now owns 57,594 shares of the business services provider’s stock valued at $743,000 after buying an additional 3,174 shares during the period. Alliancebernstein L.P. grew its position in Cross Country Healthcare by 8.7% during the second quarter. Alliancebernstein L.P. now owns 40,095 shares of the business services provider’s stock valued at $518,000 after buying an additional 3,200 shares during the period. Finally, The Manufacturers Life Insurance Company grew its position in Cross Country Healthcare by 13.3% during the second quarter. The Manufacturers Life Insurance Company now owns 28,772 shares of the business services provider’s stock valued at $372,000 after buying an additional 3,371 shares during the period. Hedge funds and other institutional investors own 92.08% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This article was first reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.americanbankingnews.com/2018/01/10/zacks-analysts-expect-cross-country-healthcare-inc-ccrn-will-post-quarterly-sales-of-226-29-million.html.

About Cross Country Healthcare

Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.

Get a free copy of the Zacks research report on Cross Country Healthcare (CCRN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.